(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -142.62%-85.73K | -76.85%-128.09K | 80.91%-201.73K | 64.63%-69.36K | -14.84%-24.6K | 80.83%-35.33K | 88.94%-72.43K | 75.10%-1.06M | 67.15%-196.12K | 97.07%-21.43K |
Net income from continuing operations | -18.69%-102.52K | -6.48%-109.27K | -126.75%-362.52K | 1.12%-89.29K | -102.72%-84.24K | 89.79%-86.38K | 87.24%-102.61K | 108.82%1.36M | 93.54%-90.31K | 342.52%3.1M |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---3.06M | ---58.2K | ---3.01M |
Depreciation and amortization | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 302.99%540 | -16,494.12%-5.57K | --0 |
Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -96.83%233.15K | --0 | -64.19%33.32K |
Change In working capital | -67.10%16.79K | -162.37%-18.83K | -61.53%160.79K | 147.41%19.93K | 141.93%59.63K | -90.86%51.05K | -30.67%30.18K | -80.33%417.94K | 88.62%-42.04K | -137.44%-142.22K |
-Change in receivables | -192.81%-2.09K | -1,885.53%-5.55K | 413.98%14.44K | 879.47%8.77K | 125.39%3.11K | -60.10%2.25K | -90.02%311 | -139.29%-4.6K | -101.01%-1.13K | 38.93%-12.24K |
-Change in prepaid assets | -70.27%2.19K | -77.69%2.19K | -93.08%20.25K | 35.80%-6.57K | -63.09%9.65K | -96.56%7.36K | -84.30%9.81K | 200.07%292.48K | -104.43%-10.23K | -80.04%26.14K |
-Change in payables and accrued expense | -59.70%16.69K | -177.07%-15.46K | -3.04%126.1K | 157.78%17.73K | 130.03%46.88K | -87.78%41.43K | 190.87%20.06K | -94.59%130.06K | 95.69%-30.68K | -158.05%-156.12K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -142.62%-85.73K | -76.85%-128.09K | 80.91%-201.73K | 64.63%-69.36K | -14.84%-24.6K | 80.83%-35.33K | 88.94%-72.43K | 75.10%-1.06M | 67.15%-196.12K | 97.07%-21.43K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 0 | 188.35%35.13K | 133.30%13.24K | 0 | |||||
Net PPE purchase and sale | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 188.35%35.13K | 133.30%13.24K | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 188.35%35.13K | 133.30%13.24K | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | -89.44%500K | ||||||||
Net common stock issuance | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -85.62%500K | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -89.44%500K | ---- | ---- |
Net cash flow | ||||||||||
Beginning cash position | -98.19%4.74K | -60.30%132.84K | -60.93%334.57K | 1,058.93%202.2K | 483.46%226.8K | 30.20%262.14K | -60.93%334.57K | 111.21%856.42K | -98.82%17.45K | -98.21%38.87K |
Current changes in cash | 132.61%11.52K | -76.85%-128.09K | 61.34%-201.73K | -121.87%-69.36K | -14.84%-24.6K | 78.25%-35.33K | 88.94%-72.43K | -215.72%-521.85K | 151.19%317.12K | 96.90%-21.43K |
End cash Position | -92.83%16.26K | -98.19%4.74K | -60.30%132.84K | -60.30%132.84K | 1,058.93%202.2K | 483.46%226.8K | 30.20%262.14K | -60.93%334.57K | -60.93%334.57K | -98.82%17.45K |
Free cash from | -142.62%-85.73K | -76.85%-128.09K | 80.91%-201.73K | 64.63%-69.36K | -14.84%-24.6K | 80.83%-35.33K | 88.94%-72.43K | 75.33%-1.06M | 69.20%-196.12K | 97.07%-21.43K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data